Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2023-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
江苏四环生物股份有限公司独立董事2022年度述职报告（徐小娟）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2022 from Jiangsu Sihuan Bio Co., Ltd. It details the independent director's attendance at board meetings, opinions on various board matters, supervisory activities, and efforts to protect investor rights. It is a narrative report on the independent director's duties and activities rather than a financial report or announcement. It does not contain financial statements or audit results, nor is it a regulatory filing or announcement of voting results. This type of document fits best under Board/Management Information (MANG), as it relates to the activities and reports of a board member (independent director). The document length is short (1301 characters), and it is a direct report, not an announcement of a report publication. Therefore, the classification is MANG with high confidence.
2023-04-26 Chinese
江苏四环生物股份有限公司关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (audit firm) for the company's 2023 financial and internal control audit. It details the qualifications, independence, and past performance of the audit firm, as well as the approval process by the board and independent directors. There are no actual financial statements or audit results included, only information about the appointment process and the audit firm. The document length is about 3,049 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit matters but is not a full annual report or audit report itself. However, since it is about the appointment of the audit firm and not the audit report results, it fits best under AR (Audit Report / Information) category rather than 10-K or RPA. Confidence is high due to clear audit firm appointment context and no financial data present. FY 2023
2023-04-26 Chinese
江苏四环生物股份有限公司独立董事2022年度述职报告（卢青）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2022 from Jiangsu Sihuan Bio Co., Ltd. It details the independent director's activities, attendance at board meetings, supervision of company governance, and protection of investor rights. The content focuses on the independent director's duties and oversight rather than financial results or audit opinions. It is not an annual report, audit report, or earnings release. It is a management or board-related report specifically from an independent director about their role and activities. This fits best under Board/Management Information (MANG) as it relates to board member duties and governance activities. The document length is short (1172 characters), and it is a report itself, not an announcement of a report publication. Therefore, the classification is MANG with high confidence.
2023-04-26 Chinese
内部控制审计报告
Regulatory Filings
2023-04-26 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2022 Annual Report Summary" of 江苏四环生物股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2022, including total assets, net profit, revenue, and quarterly financial data. It also discusses business operations, industry conditions, shareholder information, and audit opinions. The presence of comprehensive financial statements and management discussion confirms it is an annual report document rather than a brief announcement or a regulatory filing. The document length (5694 characters) supports it being a substantive report rather than a short announcement. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-26 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2022 年年度报告全文" which translates to "2022 Annual Report Full Text" for 江苏四环生物股份有限公司. It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, and a full financial report section. The document includes audited financial statements, signatures from company officers and auditors, and comprehensive financial and operational data for the full fiscal year 2022. The length of the document (15,000 characters) and the detailed content confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-26 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.